Cancer immunotherapies, such as administration of the cytokine Interleukin-2 (IL-2), adoptive cell transfer, and the checkpoint modulators CTLA-4 and PD-1, have proved effective in clinical practice (6). The gene discussed is CTLA4; the disease is cancer.